Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Koeller

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Organic & Biomolecular Chemistry|November 17, 2017
β-Alanine and N-terminal cationic substituents affect polyamide-DNA bindingBeibei Liu, Shuo Wang, Karl Aston, et al.
Anti-Cancer Drugs|August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalatorsK A Havlin, J G Kuhn, J B Craig, et al.
Journal of the National Cancer Institute|January 16, 1991
Phase I clinical and pharmacokinetic trial of flavone acetic acidK A Havlin, J G Kuhn, J B Craig, et al.
Selective Cancer Therapeutics|January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleP W Cobb, K A Havlin, J G Kuhn, et al.
Cancer Research|August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleG S Harman, J B Craig, J G Kuhn, et al.
Medicinal Chemistry|May 20, 2014
DNA Binding Polyamides and the Importance of DNA Recognition in their use as Gene-Specific and Antiviral AgentsKevin J Koeller, G Davis Harris, Karl Aston, et al.
Journal of Medicinal Chemistry|September 2, 2005
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1)Samuel J Tremont, Len F Lee, Horng-Chih Huang, et al.
Journal of Medicinal Chemistry|September 2, 2005
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2)Horng-Chih Huang, Samuel J Tremont, Len F Lee, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Organic & Biomolecular Chemistry|November 17, 2017
β-Alanine and N-terminal cationic substituents affect polyamide-DNA bindingBeibei Liu, Shuo Wang, Karl Aston, et al.
Anti-Cancer Drugs|August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalatorsK A Havlin, J G Kuhn, J B Craig, et al.
Journal of the National Cancer Institute|January 16, 1991
Phase I clinical and pharmacokinetic trial of flavone acetic acidK A Havlin, J G Kuhn, J B Craig, et al.
Selective Cancer Therapeutics|January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleP W Cobb, K A Havlin, J G Kuhn, et al.
Cancer Research|August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleG S Harman, J B Craig, J G Kuhn, et al.
Medicinal Chemistry|May 20, 2014
DNA Binding Polyamides and the Importance of DNA Recognition in their use as Gene-Specific and Antiviral AgentsKevin J Koeller, G Davis Harris, Karl Aston, et al.
Journal of Medicinal Chemistry|September 2, 2005
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1)Samuel J Tremont, Len F Lee, Horng-Chih Huang, et al.
Journal of Medicinal Chemistry|September 2, 2005
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2)Horng-Chih Huang, Samuel J Tremont, Len F Lee, et al.
Pageof 3